Skip to main content
. 2017 Jun 7;7:2989. doi: 10.1038/s41598-017-02529-y

Table 1.

Details of differential features identified between varicose and non-varicose veins groups on UP-LCMS ESI +/− and UP-LCMS HILIC +/− ESI analysis.

Met Name Mol Formula as Detected Retention Time (min) m/z (found) m/z (theor) Fold change p-value Δppm Higher in group
UP-LCMS ESI +/− (Organic extracts)
Cer(d18:0/22:0) C40H80NO2+[M+H−H2O]+ 13.49 606.6188 606.6189 −2.1 0.01 0 Non-VVs
lysoPC(18:1) C26H53NO7P+[M+H]+ 01.22 0522.3529 522.3554 −1.7 0.03 −5 Non-VVs
TG(12:0/14:0/18:1) TG(12:0/16:0/16:1) C47H92NO6+[M+NH4]+ 14.77 0766.6937 766.6919 −2.1 0.03 2 Non-VVs
TG(12:0/16:0/18:1) TG(14:0/16:1/16:0) C49H96NO6+[M+NH4]+ 15.10 0794.7231 794.7232 −1.8 0.007 0 Non-VVs
TG(14:0/16:0/18:1) C51H100NO6+[M+NH4]+ 15.42 0822.7546 822.7545 −1.6 0.002 0 Non-VVs
TG(15:0/16:0/18:1) TG(14:0/17:0/18:1)* C52H102NO6+[M+NH4]+ 15.55 0837.7767 837.7741 −1.5 0.02 3 Non-VVs
TG(16:0/16:0/18:1)* C53H104NO6+[M+NH4]+ 15.71 0851.7901 851.7897 −1.5 0.01 0 Non-VVs
PC(18:0/20:3)* C46H87NO8P+[M+H]+ 08.61 0813.6229 813.6203 1.5 0.007 3 VVs
PC(38:4)* C46H85NO8P+[M+H]+ 07.06 0811.6074 811.6047 1.4 <0.0001 3 VVs
PE(O-16:1/22:6) C43H75NO7P+[M+H]+ 06.49 0748.5290 748.5276 1.4 0.01 2 VVs
PS(16:0/22:6) C44H75NO10P+[M+H]+ 04.29 0808.5168 808.5123 1.6 0.0002 6 VVs
PS(18:0/20:1) C44H85NO10P+[M+H]+ 10.07 0818.5855 818.5906 1.5 0.0002 −6 VVs
PS(18:0/20:3) C44H81NO10P+[M+H]+ 06.65 0814.5615 814.5593 1.4 0.01 3 VVs
PS(18:0/22:6) C46H79NO10P+[M+H]+ 05.55 0836.5463 836.5436 1.7 0.003 3 VVs
SM(d18:2/24:0) C47H94N2O6P+[M+H]+ 12.77 0813.6874 813.6844 1.3 0.0007 4 VVs
SM(d18:2/24:1) C47H91N2O6PNa+[M+Na]+ 09.85 0833.6557 833.6507 1.3 0.0008 6 VVs
Cer(d40:1) C41H80NO5 [M+FA−H]− 13.49 0666.6050 666.6042 −1.2 0.01 1 Non-VVs
Alanine C3H6NO2−[M−H]− 00.54 0088.0398 88.0404 1.9 <0.0001 −7 VVs
Creatine C4H8N3O2−[M−H]− 00.54 0130.0611 130.0622 1.6 0.003 −8 VVs
Glutamine C5H8NO4−[M−H]− 00.54 0146.0459 146.0459 1.8 0.0002 0 VVs
Guanosine C10H12N5O5−[M−H]− 00.54 0282.0840 282.0844 1.4 0.005 −1 VVs
Inosine C10H11N4O5−[M−H]− 00.54 0267.0724 267.0735 1.6 0.001 −4 VVs
PC(18:0/20:3) C47H87NO10P− [M+FA−H]− 08.62 0856.6094 856.6073 1.4 0.008 2 VVs
PE(O-16:1/22:4) C43H77NO7P−[M−H]− 08.67 0750.5451 750.5443 1.2 0.004 1 VVs
PE(O-16:1/22:6) C43H73NO7P−[M−H]− 06.53 0746.5136 746.513 1.3 0.007 1 VVs
PI(18:2/18:0) C45H82O13P−[M−H]− 06.01 0861.5527 861.5499 1.4 <0.0001 3 VVs
PI(36:1) C45H84O13P−[M−H]− 07.40 0863.5676 863.5655 1.4 0.001 2 VVs
PS(16:0/22:6) C44H73NO10P−[M−H]− 04.33 0806.4999 806.4978 1.6 0.0005 3 VVs
PS(18:0/20:1) C44H83NO10P−[M−H]− 10.15 0816.5787 816.576 1.4 0.01 3 VVs
PS(18:0/20:3) C44H79NO10P−[M−H]− 06.72 0812.5485 812.5447 1.4 0.004 5 VVs
PS(18:0/22:4) C46H81NO10P−[M−H]− 07.30 0838.5630 838.5604 1.5 0.0006 3 VVs
PS(18:0/22:6) C46H77NO10P−[M−H]− 05.60 0834.5309 834.529 1.4 0.0007 2 VVs
SM(d18:2/24:0)* C47H93N2O6P−[M+FA−H]− 12.79 0858.6876 858.6781 1.3 0.0005 11 VVs
SM(d18:2/24:1) C48H92N2O8P−[M+FA−H]− 09.89 0855.6622 855.6597 1.4 <0.0001 3 VVs
Uridine C9H11N2O6−[M−H]− 00.55 0243.0616 243.0623 1.4 0.006 −3 VVs
UP-LCMS HILIC +/− Analysis (Aqueous extracts)
Creatine C4H10N3O2+[M+H]+ 6.623 132.0773 132.0767 1.3 <0.0001 4.5 VVs
Inosine C5H5N4O+[M+H]+ 6.073 137.0463 137.0457 1.3 0.007 4.3 VVs
PC (16:0/20:4) C44H81NO8P+[M+H]+ 4.737 782.5684 782.5694 1.4 0.009 −1.2 VVs
Glutamate C5H8NO4−[M−H]− 7.467 146.0455 146.0458 1.5 <0.0001 −2 VVs
Inosine C10H11N4O5−[M−H]− 3.167 267.0729 267.0734 1.24 0.01 −1.8 VVs
Taurine C2H6NO3S−[M−H]− 5.808 124.0071 124.0073 1.17 0.07 −1.6 VVs
Uridine C9H11N2O6−[M−H]− 1.517 243.0617 243.0622 1.2 0.04 −2 VVs

TG Triglyceride, PC Phosphatidylcholine, SM Sphingomyelin, PE Phosphatidylethanolamine, PS phosphatidylserine, PI phosphatidylinositols

Corrected p-values using Benjamini-Yakutieli multiple testing corrections. *Tentative assignments.